Broken-hearted women: The complex relationship between depression and cardiovascular disease

Women's Health

Volumn 5, Issue 6, 2009, Pages 709-725

  Hayes, Sharonne N ^a  

^a Mayo Clinic   (United States)

Author keywords

Antidepressant; Cardiovascular disease; Cognitive behavioral therapy; Depression; Heart disease; Selective serotonin release inhibitors; Sex specific results; Women

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANTIDEPRESSANT AGENT; ARGININE; C REACTIVE PROTEIN; ENDOTHELIN 1; INTERLEUKIN 1; INTERLEUKIN 6; NORADRENALIN; PLACEBO; RENIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ACUTE CORONARY SYNDROME; ADRENERGIC SYSTEM; AGE DISTRIBUTION; ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; BECK DEPRESSION INVENTORY; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CORONARY ARTERY BYPASS GRAFT; DEPRESSION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART RATE VARIABILITY; HEART REHABILITATION; HUMAN; HYPERCOAGULABILITY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MORTALITY; PREVALENCE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOCIAL SUPPORT; TAKOTSUBO CARDIOMYOPATHY; VASCULAR DISEASE; VASODILATATION;

AGE FACTORS; BEHAVIOR; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CAUSALITY; DEPRESSION; FEMALE; HUMANS; MASS SCREENING; MEDICATION ADHERENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; WOMEN'S HEALTH;

EID: 70649115597     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.09.56     Document Type: Review

References (138)

1. Murray C, Lopez A: Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349, 1436-1442 (1997).
2. The NSDUH report - Major depressive episode and treatment among adults. In: Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies (2009).
3. Jiang W, Krishnan RR, O'Connor CM: Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs 16, 111-127 (2002).
4. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom. Med. 66, 802-813 (2004).
5. Whang W, Kubzansky LD, Kawachi I et al.: Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J. Am. Coll. Cardiol. 53, 950-958 (2009).
6. Beck CA, Joseph L, Bélisle P: Predictors of quality of life 6 months and 1 year after acute myocardial infarction. Am. Heart J. 142(2), 271-279 (2001).
7. Lane D, Carroll D, Ring C, Beevers DG, Lip GYH: Predictors of attendance at cardiac rehabilitation after myocardial infarction. J. Psychosom. Res. 51, 497-501 (2001).
8. Parashar S, Rumsfeld JS, Spertus JA et al.: Time course of depression and outcome of myocardial infarction. Arch. Intern. Med. 166, 2035-2043 (2006).
9. Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Jaffe AS: Major depressive disorder in coronary artery disease. Am. J. Cardiol. 60, 1273-1275 (1987).
10. Gonzalez MB, Snyderman TB, Colket JT et al.: Depression in patients with coronary artery disease. Depression 4, 57-62 (1996).
11. Hance M, Carney RM, Freedland KE, Skala J: Depression in patients with coronary heart disease: a 12-month follow-up. Gen. Hosp. Psychiatry 18, 61-65 (1996).
12. Glassman AHS, Peter A: Depression and the course of coronary artery disease. Am. J. Psychiatry 155, 4-11 (1998).
13. Lesperance F, Frasure-Smith N, Talajic M: Major depression before and after myocardial infarction: its nature and consequences. Psychosom. Med. 58, 99-110 (1996).
14. Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction. Impact on 6-month survival. JAMA 270, 1819-1825 (1993).
15. Koenig HG: Depression in hospitalized older patients with congestive heart failure. Gen. Hosp. Psychiatry 20, 29-43 (1998).
16. Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, Fricchione GL: Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am. J. Cardiol. 98, 319-324 (2006).
17. Smolderen KG, Spertus JA, Reid KJ et al.: The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ. Cardiovasc. Qual. Outcomes 2, 328-337 (2009).
18. Davis J, Fujimoto RY, Juarez DT, Hodges K, Asam JK: Major depression associated with rates of cardiovascular disease state transitions. Am. J. Manag. Care 14, 125-129 (2008).
19. Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG: Gender, depression, and one-year prognosis after myocardial infarction. Psychosom. Med. 61, 26-37 (1999).
20. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA: Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 290, 215-221 (2003).
21. Wassertheil-Smoller S, Shumaker S, Ockene J et al.: Depression and cardiovascular sequelae in postmenopausal women: the Women's Health Initiative (WHI). Arch. Intern. Med. 164, 289-298 (2004).
22. Carney RM, Rich MW, Freedland KE et al.: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom. Med. 50, 627-633 (1988).
23. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 91, 999-1005 (1995). • Landmark trial demonstrating effect of depression on mortality after myocardial infarction.
24. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML: Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch. Intern. Med. 160, 1261-1268 (2000).
25. Mallik S, Krumholz HM, Lin ZQ et al.: Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation 111, 271-277 (2005).
26. Ho PM, Masoudi FA, Spertus JA et al.: Depression predicts mortality following cardiac valve surgery. Ann. Thorac. Surg. 79, 1255-1259 (2005).
27. Nicholson A, Kuper H, Hemingway H: Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur. Heart J 27, 2763-2774 (2006).
28. Rutledge T, Reis SE, Olson MB et al.: Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. Arch. Gen. Psychiatry 63, 874-880 (2006).
29. May HT, Horne BD, Carlquist JF, Sheng X, Joy E, Catinella AP: Depression after coronary artery disease is associated with heart failure. J. Am. Coll. Cardiol. 53, 1440-1447 (2009).
30. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561-571 (1961).
31. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG: Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105, 1049-1053 (2002).
32. Bush DE, Ziegelstein RC, Tayback M et al.: Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am. J. Cardiol. 88, 337-341 (2001). • Even minimal depressive symptoms elevate risk.
33. Jiang W, Alexander J, Christopher E et al.: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch. Intern. Med. 161, 1849-1856 (2001).
34. Blumenthal JA, Lett HS, Babyak MA et al.: Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362, 604-609 (2003).
35. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP: Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 358, 1766-1771 (2001).
36. Abramson J, Berger AM, Krumholz HM, Vaccarino V: Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch. Intern. Med. 161, 1725-1730 (2001).
37. Williams SA, Kasl SV, Heiat A, Abramson JL, Krumholz HM, Vaccarino VMD: Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom. Med. 64, 6012 (2002).
38. Gottlieb SS, Khatta M, Friedmann E et al.: The influence of age, gender, and race on the prevalence of depression in heart failure patients. J. Am. Coll. Cardiol. 43, 1542-1549 (2004).
39. Wellenius GA, Mukamal KJ, Kulshreshtha A, Asonganyi S, Mittleman MA: Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts. Circulation 117, 2313-2319 (2008).
40. Burt VK, Stein K: Epidemiology of depression throughout the female life cycle. J. Clin. Psychiatry 63 (Suppl. 7), 9-15 (2002).
41. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB: Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 29, 85-96 (1993).
42. Swardfager W, Herrmann N, Dowlati Y, Oh P, Kiss A, Lanctôt K: Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease. J. Rehabil. Med. 40, 213-218 (2008).
43. Failde I, Ramos I, Fernández-Palacín F, González-Pinto A: Women, mental health and health-related quality of life in coronary patients. Women Health 43, 35-49 (2006).
44. Gilmour H: Depression and risk of heart disease. Health Rep. 19, 7-17 (2008).
45. Haukkala A, Konttinen H, Uutela A, Kawachi I, Laatikainen T: Gender differences in the associations between depressive symptoms, cardiovascular diseases, and all-cause mortality. Ann. Epidemiol. 19, 623-629 (2009).
46. Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson: Depressive symptoms and treatment after acute coronary syndrome. Int. J. Cardiol. 99, 443-447 (2005).
47. Rosamond W, Flegal K, Furie K et al.: Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, E25-E146 (2008).
48. Vaccarino V, Parsons L, Every N, Barron H, Krumholz H: Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N. Engl. J. Med. 341(4), 217-225 (1999).
49. Mallik S, Spertus JA, Reid KJ et al.: Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch. Intern. Med. 166, 876-883 (2006). • Demonstrated age and gender effects of depression, potentially explaining women's excess cardiovascular disease (CVD) risk.
50. Parashar S, Rumsfeld JS, Reid KJ et al.: Impact of depression on sex differences in outcome after myocardial infarction. Circ. Cardiovasc. Qual. Outcomes 2, 33-40 (2009).
51. Pulkki-Råback L, Elovainio M, Kivimäki M et al.: Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. Health Psychol. 28, 108-116 (2009).
52. Rutledge T, Vaccarino V, Johnson BD et al.: Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) study. J. Am. Coll. Cardiol. 53, 176-183 (2009).
53. Whooley MA, De Jonge P, Vittinghoff E, Bitton A: Poor health behaviors largely explain link between depression and cardiovascular events. J. Clin. Outcomes Manag. 16, 17-18 (2009).
54. Blauwet LA, Hayes SN, McManus DN, Redberg RF, Walsh MNF: Low rate of sex-specific result reporting in cardiovascular trials. Mayo. Clin. Proc. 82, 166-170 (2007).
55. Ziegelstein RC, Kim SY, Kao D et al.: Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening? Psychosom. Med. 67, 393-397 (2005).
56. Schleifer SJ, Macari-Hinson MM, Coyle DA et al.: The nature and course of depression following myocardial infarction. Arch. Intern. Med. 149, 1785-1789 (1989).
57. Gehi AM, Dennis MD, Pipkin S, Browner WS, Whooley MA: Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch. Gen. Psychiatry 62, 661-666 (2005).
58. Joynt KE, Whellan DJ, O'Connor CM: Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J. Card. Fail. 10, 258-271 (2004).
59. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS: Association of depression with reduced heart rate variability in coronary artery disease. Am. J. Cardiol. 76, 562-564 (1995).
60. Carney RM, Blumenthal JA, Stein PK et al.: Depression, heart rate variability, and acute myocardial infarction. Circulation 107, 2024-2028 (2001).
61. Carney RM, Rich MW, TeVelde A, Saini J, Clark K, Freedland KE: The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J. Psychosom. Res. 32, 159-164 (1988).
62. Cohen H, Kotler M, Matar M, Kaplan Z: Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment: preliminary results. Isr. Med. Assoc. J. 2, 296-301 (2000).
63. McFarlane A, Kamath MV, Fallen EL, Malcolm V, Cherian F, Norman G: Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am. Heart. J. 142, 617-623 (2001).
64. Nemeroff CB, Musselman DL: Are platelets the link between depression and ischemic heart disease? Am. Heart J. 140, S57-S62 (2000).
65. Musselman DL, Tomer A, Manatunga AK et al.: Exaggerated platelet reactivity in major depression. Am. J. Psychiatry 153, 1313-1317 (1996).
66. Maes M, Van der Planken M, van Gastel A, Desnyder R: Blood coagulation and platelet aggregation in major depression. J. Affect. Disord. 40, 35-40 (1996).
67. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS: Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol. Psychiatry 42, 290-295 (1997).
68. Shimbo D, Child J, Davidson K et al.: Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am. J. Cardiol. 89, 331-333 (2002).
69. Vikenes K, Farstad M, Nordrehaug JE: Serotonin is associated with coronary artery disease and cardiac events. Circulation 100, 483-489 (1999).
70. Serebruany VL, Glassman AH, Malinin AI et al.: Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur. J. Heart Fail. 5, 517-521 (2003).
71. Agatisa PK, Matthews KA, Bromberger JT, Edmundowicz D, Chang YF, Sutton-Tyrrell K: Coronary and aortic calcification in women with a history of major depression. Arch. Intern. Med. 165, 1229-1236 (2005).
72. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B: Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am. J. Cardiol. 88, 196-198 (2001).
73. Wagner JA, Tennen H, Mansoor GA, Abbott G: History of major depressive disorder and endothelial function in postmenopausal women. Psychosom. Med. 68, 80-86 (2006).
74. Tomfohr L, Martin T, Miller G: Symptoms of depression and impaired endothelial function in healthy adolescent women. J. Behav. Med. 31, 137-143 (2008).
75. Sherwood A, Hinderliter AL, Watkins LL, Waugh RA, Blumenthal JA: Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J. Am. Coll. Cardiol. 46, 656-659 (2005).
76. Chrapko WE, Jurasz P, Radomski MW, Lara N, Archer SL, Le Mellédo JM: Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol. Psychiatry 56, 129-134 (2004).
77. van Zyl LT, Lespérance F, Frasure-Smith N et al.: Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. J. Thromb. Thrombolysis 27, 48-56 (2009).
78. Ridker PM, Friedewald VE, Davidson MH, Willerson JT, Roberts WC: The editor's roundtable: the JUPITER trial - initial results and clinical implications. Am. J. Cardiol. 103, 1417-1425 (2009).
79. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA: Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Cardiol. 90, 1279-1283 (2002).
80. Vaccarino V, Johnson BD, Sheps DS et al.: Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J. Am. Coll. Cardiol. 50, 2044-2050 (2007).
81. Appels AB, Bär FW, Bär J, Bruggeman C, de Baets M: Inflammation, depressive symptomatology, and coronary artery disease. Psychosom. Med. 62, 601-605 (2000).
82. Lesperance F, Frasure-Smith N, Theroux P, Irwin M: The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am. J. Psychiatry 161, 271-277 (2004).
83. Musselman DL, Marzec UM, Manatunga A et al.: Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch. Gen. Psychiatry 57, 875-882 (2000).
84. Serebruany VL, Glassman AH, Malinin AI et al.: Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 108, 939-944 (2003).
85. Blumenthal JA, Williams RS, Wallace AG, Williams RB Jr, Needles TL: Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom. Med. 44, 519-527 (1982).
86. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160, 2101-2107 (2000).
87. Moser DK, Worster PL: Effect of psychosocial factors on physiologic outcomes in patients with heart failure. J. Cardiovasc. Nursing. 14, 106-115 (2000).
88. Evangelista LS, Berg J, Dracup K: Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung 30, 294-301 (2001).
89. Taylor DK, Barber KR, McIntosh BA, Khan M: The impact of post acute myocardial infarction (AMI) depression on patient compliance and risk factor modification. Psychol. Health Med. 3, 439-442 (1998).
90. Gehi A, Haas D, Pipkin S, Whooley MA: Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch. Intern. Med. 165, 2508-2513 (2005).
91. Rieckmann N, Kronish IM, Haas D et al.: Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am. Heart J. 152, 922-927 (2006).
92. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE: Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med. 160, 1818-1823. (2000).
93. Glazer KM, Emery CF, Frid DJ, Banyasz RE: Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J. Cardiopulm. Rehabil. 22, 40-46 (2002).
94. Kronish IM, Rieckmann N, Halm EA et al.: Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J. Gen. Intern. Med. 21, 1178-1183 (2006).
95. Gehi AK, Ali S, Na B, Whooley MA: Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch. Intern. Med. 167, 1798 - 1803 (2007).
96. Whooley MA, de Jonge P, Vittinghoff E et al.: Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300, 2379-2388 (2008).
97. Frasure-Smith N, Lesperance F: Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch. Gen. Psychiatry 65, 62-71 (2008).
98. Mosca L, Banka CL, Benjamin EJ et al.: Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J. Am. Coll. Cardiol. 49, 1230-1250 (2007).
99. Lichtman JH, Bigger JT, Blumenthal JA et al.: Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation 118, 1768-1775 (2008). •• American Heart Association guidelines recommend screening for depression in patients with CVD, but leave the treatment plan up to the provider.
100. Spitzer RL, Kroenke K, Williams JBW, and the Patient Health Questionnaire Primary Care Study G: Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care study. JAMA 282, 1737-1744 (1999).
101. Thombs B, Ziegelstein R, Whooley M: Optimizing detection of major depression among patients with coronary artery disease using the Patient Health Questionnaire: data from the Heart and Soul study. J. Gen. Intern. Med. 23, 2014-2017 (2008).
102. Thombs B, Bass E, Ford D et al.: Prevalence of depression in survivors of acute myocardial infarction. J. Gen. Intern. Med. 21, 30-38 (2006).
103. Linke SE, Rutledge T, Johnson DB et al.: Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch. Gen. Psychiatry 66, 499-507 (2009).
104. Silverstein BP: Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am. J. Psychiatry 156, 480-482 (1999).
105. Spertus JA, McDonell M, Woodman CL, Fihn SD: Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am. Heart J. 140, 105-110 (2000).
106. Rutledge T, Reis SE, Olson M et al.: Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE study. Psychosom. Med. 68, 217-223 (2006). • Sex-specific data confirm a depression-CVD interaction in the Women's Ischemia Syndrome Evaluation cohort.
107. Glassman AH, O'Connor CM, Califf RM et al.: Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288, 701-709. (2002). •• First study to clearly demonstrate safety of selective serotonin-reuptake inhibitors in cardiac patients.
108. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55, 580-592 (1998).
109. Thombs BD, de Jonge P, Coyne JC et al.: Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 300, 2161-2171 (2008).
110. Berkman LF, Blumenthal J, Burg M et al.: Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 289, 3106-3116 (2003). •• Landmark trial with disappointing results.
111. Frasure-Smith N, Lespérance F, Prince RH et al.: Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 350, 473-479 (1997).
112. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Bourassa MG: Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal Heart Attack Readjustment Trial. Psychosom. Med. 64, 571-579 (2002).
113. Cossette S, Frasure-Smith N, Lespérance F: Nursing approaches to reducing psychological distress in men and women recovering from myocardial infarction. Int. J. Nurs. Stud. 39, 479-494 (2002).
114. Saab PG, Bang H, Williams RB et al.: The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. J. Psychosom. Res. 67, 45-56 (2009).
115. Orth-Gomer K, Schneiderman N, Wang HX, Walldin C, Blom M, Jernberg T: Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD). Circ. Cardiovasc. Qual. Outcomes (2009). • Small trial, but demonstrated mortality reduction in women who enrolled in sex-specific support groups and received cognitive-behavioral therapy.
116. Paraskevaidis I, Parissis JT, Fountoulaki K, Filippatos G, Kremastinos D: Selective serotonin reuptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: evidence for pleiotropic effects Cardiovasc. Hematol. Agents Med. Chem. 4, 361-367 (2006).
117. Sauer WH, Berlin JA, Kimmel SE: Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104, 1894-1898 (2001).
118. Ziegelstein RC, Meuchel J, Kim TJ et al.: Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am. J. Med. 120, 525-530 (2007).
119. Taylor CB, Youngblood ME, Catellier D et al.: Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatry 62, 792-798 (2005).
120. O'Connor CM, Jiang W, Kuchibhatla M et al.: Antidepressant use, depression, and survival in patients with heart failure. Arch. Intern. Med. 168, 2232-2237 (2008).
121. Tata LJ, West J, Smith C et al.: General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 91, 465-471 (2005).
122. Kim DH, Daskalakis C, Whellan DJ et al.: Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am. J. Cardiol. 103, 1391-1395 (2009).
123. Lesperance F, Frasure-Smith N, Koszycki D et al.: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297, 367-379 (2007).
124. Milani RV, Lavie CJ, Cassidy MM: Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am. Heart J. 132, 726-732. (1996).
125. Kugler J, Seelbach H, Kruskemper GM: Effects of rehabilitation exercise programmes on anxiety and depression in coronary patients: a meta-analysis. Br. J. Clin. Psychol. 33, 401-410 (1994).
126. Thomas RJ, King M, Lui K et al.: AACVPR/ ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services: endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 50, 1400-1433 (2007).
127. Lavie CJ, Milani RV, Cassidy MM, Gilliland YE: Effects of cardiac rehabilitation and exercise training programs in women with depression. Am. J.Cardiol. 83, 1480-1483 (1999).
128. Blumenthal JA, Babyak MA, Doraiswamy PM et al.: Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom. Med. 69, 587-596 (2007).
129. Witt BJ, Jacobsen SJ, Weston SA et al.: Cardiac rehabilitation after myocardial infarction in the community. J. Am. Coll. Cardiol. 44, 988-996 (2004).
130. Suaya JA, Shepard DS, Normand SLT, Ades PA, Prottas J, Stason WB: Use of cardiac rehabilitation by medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 116, 1653-1662 (2007).
131. Cooper AF, Jackson G, Weinman J, Horne R: Factors associated with cardiac rehabilitation attendance: a systematic review of the literature. Clin. Rehabil. 16, 541-552 (2002).
132. Ades PA, Waldmann ML, Polk D, Coflesky J: Referral patterns and exercise response in the rehabilitation of female coronary patients aged greater than or equal to 62 years. Am. J. Cardiol. 69, 1422-1425 (1992).
133. Evenson KR, Fleury J: Barriers to outpatient cardiac rehabilitation participation and adherence. J. Cardiopulm. Rehabil. Prev. 20, 241-246 (2000).
134. Gallagher R, McKinley S, Dracup K: Predictors of women's attendance at cardiac rehabilitation programs. Prog. Cardiovasc. Nurs. 18, 121-126 (2003).
135. Farley RL, Wade TD, Birchmore L: Factors influencing attendance at cardiac rehabilitation among coronary heart disease patients. Eur. J. Cardiovasc. Nurs. 2, 205-212 (2003).
136. Missik E: Women and cardiac rehabilitation: accessibility issues and policy recommendations. Rehabil. Nurs. 26, 141-147 (2001).
137. Lieberman L, Meana M, Stewart D: Cardiac rehabilitation: gender differences in factors influencing participation. J. Womens Health 7, 717-723 (1998).
138. Diagnostic and Statistical Manual (DSM-IVTR ™), First MB (Ed.). (2000)